TRAITEMENT DE MALADIES ASSOCIÉES AUX GÈNES LIÉS AU SYNDROME DE DOWN PAR INHIBITION DES GÈNES LIÉS AU SYNDROME DE DOWN MÉDIÉE PAR LE PRODUIT DE TRANSCRIPTION ANTISENS NATUREL
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Down Syndrome Gene, in particular, by targeting natural antisense polynucleotides of a Down Syndrome Gene. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Down Syndrome Genes.